Cargando…
New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters
Genome sequencing of Streptomyces, myxobacteria, and fungi showed that although each strain contains genes that encode the enzymes to synthesize a plethora of potential secondary metabolites, only a fraction are expressed during fermentation. Interest has therefore grown in the activation of these c...
Autores principales: | Ochi, Kozo, Hosaka, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536979/ https://www.ncbi.nlm.nih.gov/pubmed/23143535 http://dx.doi.org/10.1007/s00253-012-4551-9 |
Ejemplares similares
-
Silent hypoxia in COVID-19: pathomechanism and possible management strategy
por: Rahman, Ahsab, et al.
Publicado: (2021) -
Clinical and Pathological Aspects of Silent Pituitary Adenomas
por: Drummond, Juliana, et al.
Publicado: (2018) -
New Molecules in Babesia gibsoni and Their Application for Diagnosis, Vaccine Development, and Drug Discovery
por: Goo, Youn-Kyoung, et al.
Publicado: (2014) -
Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery
por: Lounnas, Valère, et al.
Publicado: (2013) -
Computer-Aided Drug Discovery in Plant Pathology
por: Shanmugam, Gnanendra, et al.
Publicado: (2017)